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polymorphismAbstract Mild gestational hyperglycemia (MGH) is a very common complication of pregnancy
that is characterized by intolerance to glucose. The association of angiotensin-converting enzyme
(ACE) insertion/deletion (I/D) polymorphism to MGH has been previously reported. In this study,
we evaluated the association between ACE polymorphism and the risk of MGH in a Saudi popu-
lation. We conducted a case-control study in a population of 100 MGH patients and 100 control
subjects. ACE gene polymorphism was analyzed by the novel approach of tetraprimer ampliﬁcation
refractory mutation system (ARMS)-polymerase chain reaction (PCR). The frequency of ACE
polymorphism was not associated with either alleles or genotypes in MGH patients. Glucose con-
centration was found to be signiﬁcantly associated with the MGH group. Our study suggests that
ACE genotypes were not associated with ACE polymorphism in a Saudi population.
ª 2014 The Author. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is
an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Mild gestational hyperglycemia (MGH) or gestational diabetes
is a common complication that is characterized by glucose
intolerance manifested during the initial phase of pregnancy
(Gilder et al., 2014). The prevalence of MGH increases propor-
tional to the rate of obesity and type 2 DM (T2DM), and
women with MGH are at an increased risk of developing
T2DM (Weinert et al., 2014). The prevalence of MGH varies
in different populations or ethnic groups; in fact, the prevalencerate is 18.7% (Khan et al., 2013; Wahabi et al., 2013). The
known risk factors for MGH include pre-pregnancy over-
weight, obesity, advanced maternal age, and a family history
of T2DM or MGH (Zhang et al., 2013). The genetic back-
ground of T2DM may be applied to MGH because signiﬁcant
evidence demonstrates the prevalence of T2DM in women with
MGH (Chon et al., 2013). MGH and T2DM are heteroge-
neous disorders, and the common pathophysiology and genetic
variants between them can be used to determine the risk of
T2DM, which may in turn be associated with the prevalence
of MGH (Cho et al., 2009). Normal human pregnancy is char-
acterized with hyperinsulinemia and a progressive decline in
insulin sensitivity, which is compensated by increased insulin
secretion to maintain the glucose homeostasis (Fallucca
et al., 2006; Tok et al., 2006). Several studies have revealed
common gene polymorphisms between MGH and T2DM
(Khan et al., 2014). Recently, several parallel studies were per-
formed to establish the relationship among functional variants
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analysis, and candidate genes in T2DM. Angiotensin-convert-
ing enzyme (ACE) gene is an important gene that inﬂuences
the vascular structure, and abnormalities in ACE may result
in T2DM (Al-Harbi et al., 2012), diabetic nephropathy
(Rahimi, 2012), end-stage renal disease (Zhou et al., 2012),
and gestational diabetes (Khan et al., 2013). ACE activity
was strongly inﬂuenced by ACE polymorphism; speciﬁcally,
I/D polymorphism of ACE accounted for 47% of the total
phenotypic variance of plasma ACE. Subjects with DD
(Deletion/Deletion) allele showed two-time higher ACE
activity than subjects with an Insertion/Insertion (II) allele
Purnamasari et al., 2012. The rennin–angiotensin system
(RAS) (renin, angiotensin I, angiotensin II, and ACE) plays
an important role in regulating the cardiovascular homeostasis
(Xie et al., 2013). The human ACE is located on the chromo-
some 17q23 and has several variants such as rs4646994,
rs8066114, and rs4461142. One of the most important ACE
polymorphisms is a 287 bp Alu I/D sequence polymorphism
in intron 16; it is a nonsense, repetitive DNA domain that
leads to the generation of three genotypes: II, ID, and DD
(Lin et al., 2014; Simsek et al., 2013). There exists no report
of effect of ACE polymorphism on MGH risk in a Saudi pop-
ulation. Therefore, we aimed to investigate ACE polymor-
phism, discovered and described by Rigat et al. (1992) in
pregnant women with MGH.2. Materials and methods
2.1. Screening
A case-control study was conducted in pregnant women to
estimate their blood glucose values during pregnancy to test
for MGH as well as to perform insertion and polymorphism
studies. The study group comprised of 100 unrelated pregnant
women with MGH and 100 unrelated healthy controls selected
from the Department of Gynecology and Obstetrics. All
women participants in this study provided a signed written
informed consent form before collection of their blood
samples.
2.2. Selection
The diagnosis of MGH/GDM was based on 50 g glucose
challenge test (GCT) and 100 g oral glucose tolerance test
(OGTT) performed during the 24–28 weeks of pregnancy
as a universal screening test. GCT was performed on all
pregnant women. The plasma glucose standard of
>7.8 mmol/L was considered as GCT-positive. Before
OGTT, pregnant women were advised to fast overnight in
addition to 3 days of an unrestricted diet. Fasting plasma
samples were drawn after 1, 2, and 3 h of glucose adminis-
tration to perform the 100 g OGTT test. In this study, the
abnormality values established by Carpenter and Coustan
criteria (Carpenter and Coustan, 1982) were followed. Preg-
nant women with abnormal glucose tolerance tests were
included in the study. Dietary adjustments and, if necessary,
insulin therapy were used to attain glycemic control in
MGH women (Beneventi et al., 2014).2.3. Blood test
A total of 6 mL peripheral blood sample was collected, of
which 3 mL blood was collected in a ﬂuoride vacutainer tube
to separate the serum from the blood and 3 mL blood was col-
lected in an ethylenediaminetetraaceticacid (EDTA) vacutainer
tube for DNA separation. Serum samples were used to evalu-
ate the fasting blood sugar (FBS), postprandial blood glucose
(PPBG), GCT and OGTT values (Al-Daghri et al., 2014). The
body mass index (BMI) was calculated as weight/height2 (kg/
m2). The Bio-Rad DNA Extraction Kit was used to extract
DNA from the collected peripheral blood leucocytes, and the
DNA was stored at 80 C until use.
2.4. Analysis of tetraprimer ampliﬁcation refractory mutation
system (ARMS)-polymerase chain reaction (PCR)
The oligonucleotide sequences for PCR primers (tetraprimers)
for I/D alleles were selected from prior studies conducted in
different populations (Rigat et al., 1992; Masud and Qureshi,
2011). Genotyping for ACE was accomplished by direct
PCR, and successful ampliﬁcation was conﬁrmed by electro-
phoresis on 2% agarose gel. PCR reactions were performed
in a thermal cycler with initial denaturation at 95 C for
5 min, followed by 35 ampliﬁcation cycles of denaturation at
95 C for 30 s, 60 C for 30 s, 72 C for 45 s, and a ﬁnal exten-
sion at 72 C for 5 min. Major allele indicates the 490 bp frag-
ment that embraces 287 bp Alu sequence, known as an
insertion, whereas the 190 bp fragment represents the minor
allele with the deletion of Alu sequence. Heterozygosity speci-
ﬁes the combination of both major and minor fragments i.e.
490/190 bp.
2.5. Statistical analysis
Statistical package for the social sciences (SPSS) software for
windows (version 21.0., Chicago, IL, USA) was used to per-
form the statistical analysis. Hardy–Weinberg Equilibrium
(HWE) was tested for MGH and control women. The allelic
frequencies were calculated based on the number of different
alleles observed and the total number of alleles examined.
The allele and genotype frequency differences between MGH
patients and control subjects were tested by chi-square analy-
sis. Odds ratios (ORs) and 95% conﬁdence intervals were cal-
culated by multiple logistic regression analysis. Results of
continuous variables were expressed using a descriptive statis-
tic [mean ± standard deviation (SD)] and analyzed by Stu-
dent’s t-test. Analysis of variance (ANOVA) was used to
compare the genotype group differences for various parame-
ters. p < 0.05 was considered statistically signiﬁcant.
3. Results
3.1. Women characteristics
Clinical and biochemical characteristics of MGH and controls
were similar (Table 1), whereas the anthropometric measure-
ments such as age, weight, height, and BMI remained the same
(p> 0.05). Biochemical tests including FBS, PPBG, GCT, and
Table 1 Clinical characteristics of MGH cases and control subjects in Saudi women.
MGH cases (n= 100) Controls (n= 100) p value
Age (Years) 31.9 ± 5.6 31.3 ± 6.0 0.55
Weight (kg) 79.1 ± 13.4 74.1 ± 12.1 0.12
Height (m2) 155.1 ± 5.9 157.1 ± 5.3 0.08
BMI (kg/m2) 34.1 ± 4.2 33.2 ± 4.2 0.16
Mean gestational age 30.3 ± 5.7 NA NA
FBS (mmol/L) 5.0 ± 0.9 4.5 ± 0.8 <0.001
PPBG (mmol/L) 6.5 ± 2.0 4.4 ± 1.8 0.001
GCT (mmol/L) 9.5 ± 1.8 6.3 ± 1.5 <0.001
OGTT (Fasting hour) 5.2 ± 1.18 4.5 ± 0.87 <0.001
OGTT (1st hour) 10.7 ± 1.8 8.0 ± 1.7 <0.001
OGTT (2nd hour) 9.2 ± 1.8 6.7 ± 1.6 <0.001
OGTT (3rd hour) 5.6 ± 1.7 4.5 ± 1.3 <0.001
All continuous variables represented by mean ± standard deviation. Independent sample t-test is done comparing MGH and control subjects.
Categorical variables compared using chi-square analysis. p< 0.05 considered signiﬁcant. NA= not applicable/not analyzed.
Insertion/Deletion gene polymorphism studies 329OGTT performed for all pregnant women were found to be
signiﬁcant (p< 0.05).
3.2. Molecular analysis
The distribution of the genotype frequencies of ACE polymor-
phism in control subjects was in accordance with the HWE.
The distribution of genotype and allele frequencies of I/D
polymorphism in MGH and controls was determined to exam-
ine their association with the risk for MGH (Table 2). The fre-
quencies of II, ID, and DD genotypes for MGH patients and
control women were 17%, 30%, and 53% and 15%, 40%, and
45%, respectively. No signiﬁcant difference was noted between
the allele frequencies of MGH and controls (OR 1.14 [95%CI:
0.75–1.73]; p= 0.40).
3.3. Correlation of I28005D genotypes with clinical
and biochemical parameters
In the present study, the I28005D polymorphism was found to
be correlated with the II, ID, and DD genotypes, based on the
anthropometric, clinical, and biochemical parameters. Our
analysis revealed that DD genotype in combination with II
and ID was signiﬁcantly associated with elevated PPBG and
GCT (p< 0.05). On the contrary, DD genotype was
signiﬁcantly related to a decreased 3 h OGTT level as
compared to II and ID genotypes (Table 3).Table 2 Dissemination of ACE gene I/D polymorphism and allele
Genotypes GDM cases (n= 100)% Non-GDM (1=
II 17 (17%) 15 (15%)
ID 30 (30%) 40 (40%)
DD 53 (53%) 45 (45%)
ID+ II 47 (47%) 55 (55%)
ID+ DD 83 (83%) 85 (85%)
II + DD 70 (70%) 60 (60%)
Alleles
I 64 (0.32) 70 (0.35)
D 136 (0.68) 130 (0.65)4. Discussion
This is the ﬁrst report employing tetraprimer ARMS-PCR for
genotyping ACE with I and D polymorphisms in pregnant
women, including 200 pregnant Saudi women (100 MGH
and 100 control subjects). We investigated the relationship
between ACE (I/D) and MGH. Until date, screening and iden-
tiﬁcation of MGH have been performed by the biochemical
examination of serum samples, despite the advancement in
genetic screening methods. No genetic test is available to iden-
tify MGH in pregnant women (Carpenter and Coustan, 1982).
To the best of our knowledge, this is the ﬁrst study conducted
on pregnant Saudi women. In this study, we investigated the
effects of I/D of the ACE variants. Results of our study
revealed that none of the genotypes of ACE were signiﬁcantly
associated with the risk for MGH.
The RAS is primarily involved in the regulation of blood
pressure and serum electrolytes. The biological mechanism of
ACE includes conversion of angiotensin I to a potent vasocon-
strictor angiotensin II by a metalloenzyme that leads to
inactivation of bradykinin, which is a vasodilator of the
kallikrein–kinin system and has major implication in the
inﬂammatory process including osteoarthritis (Inanir et al.,
2013). Although the accurate mechanism of development of
MGH/ gestational diabetes during pregnancy is unknown, it
can be characterized by progressive insulin resistance resulting
from a combination of increased maternal adiposity andfrequencies between MGH patients and control subjects.
100) v2 p value Odds ratio (95% CI)
Reference
0.92 0.33 0.66 (0.28–1.55)
0.008 0.92 1.03 (0.46–2.31)
0.48 0.62 0.75 (0.34–1.67)
0.14 0.69 0.86 (0.40–1.83)
0.005 0.52 1.02 (0.47–2.23)
Reference
0.40 0.52 1.14 (0.75–1.73)
Table 3 Distribution of MGH characteristics according to anthropometric and metabolic parameters in ACE genotypes.
Aspects II (n= 17) ID (n= 30) DD (n= 53) v2 p
Age (Years) 32.55 ± 6.47 33.68 ± 5.74 31.68 ± 5.43 1.62 0.44
Age of onset 30.76 ± 5.41 29.9 ± 5.57 30.22 ± 6.17 1.25 0.53
BMI (kg/m2) 31.25 ± 4.78 31.79 ± 4.46 29.22 ± 4.52 0.21 0.89
FBS (mmol/L) 6.37 ± 2.59 5.65 ± 2.86 6.44 ± 2.29 3.88 0.14
PPBG (mmol/L) 9.82 ± 3.79 9.84 ± 2.57 9.87 ± 3.63 9.41 0.009
GCT (mmol/L) 7.91 ± 2.52 8.15 ± 2.29 8.33 ± 3.04 6.19 0.04
OGTT (Fasting hour) 5.07 ± 1.18 5.26 ± 1.16 5.11 ± 1.20 0.08 0.95
OGTT (1st hour) 8.14 ± 5.03 7.01 ± 5.60 8.34 ± 4.60 2.99 0.22
OGTT (2nd hour) 6.76 ± 4.08 5.69 ± 4.76 7.28 ± 4.08 2.02 0.36
OGTT (3rd hour) 5.12 ± 1.98 3.17 ± 3.3 3.50 ± 2.91 9.63 0.008
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human placental lactogen, estrogen, and prolactin (Khan
et al., 2014). The molecular mechanism of the association
between ACE I/D polymorphism and the risk of MGH are rel-
atively unclear. ACE has 26 exons: exons 1–12 encode for the
amino domain and exons 13–26 encode for the carboxyl
domain. A commonly occurring variant of ACE has I/D poly-
morphism with a 287 bp Alu repetitive sequence in intron 16
(Chmaisse et al., 2009). We examined polymorphism of
ACE, which is an important gene in the RAS, in MGH/gesta-
tional diabetes women and healthy controls in a Saudi popula-
tion. The frequency of DD genotype was not signiﬁcantly
different among MGH patients (p= 0.92). The frequency of
D allele showed no statistical difference between MGH
patients and control subjects (p= 0.53). ACE may be consid-
ered as a risk factor for the development of T2DM and its
complications. Although this polymorphism occurs in the
intronic region of the gene, a past study showed that DD geno-
type is strongly associated with increased plasma or serum
ACE levels, thereby predisposing individuals to T2DM and
its complications (Chmaisse et al., 2009).
The relationship between ACE polymorphism and gesta-
tional diabetes has previously been studied mainly in the
women of Brno and Indian population (Khan et al., 2013;
Dostalova et al., 2006). Reports on no association of ACE
polymorphism with MGH in women (Dostalova et al., 2006)
are consistent with those reporting a positive association in
the Brno population (Dostalova et al., 2006). Results of the
present study support data in the literature, suggesting a posi-
tive association between ACE polymorphism and MGH.
ACE variants do not show single nucleotide polymor-
phisms (SNP), but I/D polymorphism and the insertion allele
represent repetitive sequences of Alu with the difference of
287 bp between the I/D alleles. Because of the differences
between the repeat sequences of the two ACE alleles, a conven-
tional PCR was used instead of the tetraprimer ARMS-PCR
(Masud and Qureshi, 2011). The tetraprimer ARMS-PCR
employs intelligently designed primer sets consisting of two
outer non-speciﬁc primer and two inner, allele-speciﬁc primers
oriented opposite to each other. In a single reaction, the outer
primers amplify a large fragment of the target gene, irrespec-
tive of its genotype, which serves as an internal control, while
each of the inner primer combines with the respective opposite
outer primer to generate smaller allele-speciﬁc amplicons. In
order to increase the allele speciﬁcity, a deliberate mismatch
is incorporated into the nested primers at position 2 or 3
from the 30 terminus (Lajin et al., 2012; Etlik et al., 2011).However, the role of ACE in MGH women or pregnant
women is unclear, with very few studies addressing the associ-
ation between ACE polymorphism and MGH. Furthermore,
there are no studies on the association between ACE serum
levels and MGH in women. Therefore, the contribution of
ACE activity to the development of MGH warrants further
investigation.
The limitation of our present study included (i) lack of mea-
surement of the ACE levels and (ii) use of only one snip. How-
ever, our study does not report a signiﬁcant association of
ACE I/D polymorphism in MGH women. Based on these
results, we concluded that MGH was not inﬂuenced by ACE
polymorphism in Saudi women. Further studies are required
to fully understand the role and determinants of ACE activities
and ACE levels in different ethnic groups.
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